Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method.: Influence of the surfactant on preparation and hydrophobic drug loading

被引:55
作者
Lemos-Senna, E
Wouessidjewe, D
Lesieur, S
Duchêne, D
机构
[1] Universite Joseph Fourier, Fac Pharm, Pharm Galen Lab, F-38243 Meylan, France
[2] Univ Paris Sud, Fac Pharm, Lab Physicochim Pharmacotech Biopharm, URA 1218, F-92296 Chatenay Malabry, France
关键词
amphiphilic cyclodextrins; emulsification evaporation method; nanospheres; progesterone;
D O I
10.1016/S0378-5173(98)00147-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In this study we verified the feasibility of preparing nanospheres from an amphiphilic 2,3-di-O-hexanoyl-gamma-cyclodextrin (gamma CDC6) using the emulsification solvent evaporation method. This preparation method consists in emulsifying an organic phase containing the cyclodextrin in an aqueous phase containing Pluronic F68 as surfactant. The influence of the process parameters, i.e. surfactant concentration and initial gamma CDC6 content, on the characteristics of nanosphere preparation, as well as on the nanosphere loading of a hydrophobic drug, progesterone, was evaluated. Cyclodextrin nanospheres presenting a mean diameter varying from 50 to 200 nm were obtained, even in the presence of low surfactant concentration. The formation of colloidal particles in these conditions was associated with the amphiphilic properties of the cyclodextrin derivative. However the partitioning of the gamma CDC6 molecule between the organic and aqueous phases was observed as being a function of surfactant concentration in the continuous phase. This partitioning was related to the formation of very small aggregates of the order 10 to 20 nm, probably Pluronic F68/gamma CDC6 mixed micelles as evidenced by the micrographs obtained by TEM. In the case of the nanospheres loaded with progesterone, the partitioning of the drug between the dispersed phase containing the cyclodextrin and the continuous aqueous phase containing Pluronic F68/gamma CDC6 aggregates was also demonstrated. The drug content found in the final nanospheres ranged from 4 to 5% (w/w) of the carrier. Finally, dilution experiments were carried out to evaluate the stability of the drug particle association. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:119 / 128
页数:10
相关论文
共 18 条
[1]   IN-VITRO EXTENDED-RELEASE PROPERTIES OF DRUG-LOADED POLY(DL-LACTIC ACID) NANOPARTICLES PRODUCED BY A SALTING-OUT PROCEDURE [J].
ALLEMANN, E ;
LEROUX, JC ;
GURNY, R ;
DOELKER, E .
PHARMACEUTICAL RESEARCH, 1993, 10 (12) :1732-1737
[2]   PREPARATION OF AQUEOUS POLYMERIC NANODISPERSIONS BY A REVERSIBLE SALTING-OUT PROCESS - INFLUENCE OF PROCESS PARAMETERS ON PARTICLE-SIZE [J].
ALLEMANN, E ;
GURNY, R ;
DOELKER, E .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 87 (1-3) :247-253
[3]   POLOXAMER ASSOCIATION IN AQUEOUS-SOLUTION [J].
ALSADEN, AA ;
WHATELEY, TL ;
FLORENCE, AT .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1982, 90 (02) :303-309
[4]   SOLVENT SELECTION IN THE PREPARATION OF POLY(DL-LACTIDE) MICROSPHERES PREPARED BY THE SOLVENT EVAPORATION METHOD [J].
BODMEIER, R ;
MCGINITY, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 43 (1-2) :179-186
[6]   POLYLACTIC ACID MICROSPHERES CONTAINING QUINIDINE BASE AND QUINIDINE SULFATE PREPARED BY THE SOLVENT EVAPORATION TECHNIQUE .1. METHODS AND MORPHOLOGY [J].
BODMEIER, R ;
MCGINITY, JW .
JOURNAL OF MICROENCAPSULATION, 1987, 4 (04) :279-288
[7]   INDOMETHACIN POLYMERIC NANOSUSPENSIONS PREPARED BY MICROFLUIDIZATION [J].
BODMEIER, R ;
CHEN, HG .
JOURNAL OF CONTROLLED RELEASE, 1990, 12 (03) :223-233
[8]  
Fessi H, 1988, US Patent, Patent No. 5118528
[9]   THE PREPARATION AND CHARACTERIZATION OF POLY(LACTIDE-CO-GLYCOLIDE) MICROPARTICLES .1. OIL-IN-WATER EMULSION SOLVENT EVAPORATION [J].
JEFFERY, H ;
DAVIS, SS ;
OHAGAN, DT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 77 (2-3) :169-175
[10]  
KATAOKA K, 1993, J CONTROL RELEASE, V24, P119